However, to further characterize the influence of the Fc-tamed antibodies on rare Fc-mediated effects, including potentially reduced thrombocytopenia, trogocytosis, immune complex clearance and activation of CD32b-positive scavenger endothelial cells, in vivo studies should be considered (41). Here, FCGR2B is linked to Thrombocytopenia.